Background

roda-blodceller-liv-diagnostics

About 1 in 3 of us risk developing cancer1. Today, there are good opportunities for treatment of primary tumors, but if the tumor cells spread in the body via metastasis, treatment options become considerably more limited. This is a severe problem as metastasis causes 90% of all deaths from cancer2.The key to successful treatment is to identify the migration potential in the tumor cells and to treat cancer optimally.

We have chosen to start our development work within breast cancer, which, together with prostate cancer, is the most common cancer form3. WHO has estimated that there were 1.7 million new cases of breast cancer in 2012. It is generally estimated that the incidence of cancer will increase by 70% over the next 20 years3.
Therefore, it is important to note that after further development CellRACE has the potential to be used in other cancer forms.

1) Cancerfondsrapporten 2016
2) Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006 Jun;6(6):449-58.WHO/Cancerfonden
3) Cancerfondsrapporten 2016, WHO